Genenta Science SpA ADR (GNTA)vsLockheed Martin Corporation (LMT)
GNTA
Genenta Science SpA ADR
$0.62
+2.48%
INDUSTRIALS · Cap: $30.38M
LMT
Lockheed Martin Corporation
$643.70
+2.20%
INDUSTRIALS · Cap: $126.53B
Smart Verdict
WallStSmart Research — data-driven comparison
LMT leads profitability with a 8.2% profit margin vs 0.0%. LMT earns a higher WallStSmart Score of 69/100 (B-).
GNTA
Avoid23
out of 100
Grade: F
LMT
Strong Buy69
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for GNTA.
Margin of Safety
-70.3%
Fair Value
$354.67
Current Price
$643.70
$289.03 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Every $100 of equity generates 65 in profit
Earnings expanding 443.8% YoY
Large-cap with strong market position
Generating 3.0B in free cash flow
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Trading at 16.9x book value
Weak financial health signals
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : GNTA
The strongest argument for GNTA centers on Price/Book.
Bull Case : LMT
The strongest argument for LMT centers on Return on Equity, EPS Growth, Market Cap. Revenue growth of 10.5% demonstrates continued momentum. PEG of 1.02 suggests the stock is reasonably priced for its growth.
Bear Case : GNTA
The primary concerns for GNTA are Revenue Growth, EPS Growth, Market Cap.
Bear Case : LMT
The primary concerns for LMT are Price/Book, Piotroski F-Score, Debt/Equity. Debt-to-equity of 2.04 is elevated, increasing financial risk.
Key Dynamics to Monitor
GNTA carries more volatility with a beta of 0.76 — expect wider price swings.
LMT is growing revenue faster at 10.5% — sustainability is the question.
LMT generates stronger free cash flow (3.0B), providing more financial flexibility.
Monitor CONGLOMERATES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
LMT scores higher overall (69/100 vs 23/100) and 10.5% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Genenta Science SpA ADR
INDUSTRIALS · CONGLOMERATES · USA
Genenta Science SpA, a clinical-stage biotechnology company, is dedicated to the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company is headquartered in Milan, Italy.
Visit Website →Lockheed Martin Corporation
INDUSTRIALS · AEROSPACE & DEFENSE · USA
Lockheed Martin Corporation is an American aerospace, defense, information security, and technology company with worldwide interests. It is headquartered in North Bethesda, Maryland, in the Washington, D.C., area.
Visit Website →Compare with Other CONGLOMERATES Stocks
Want to dig deeper into these stocks?